Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic eculizumab in ABO-incompatible kidney transplantation without plasmapheresis
jRCTs031250214Recruiting
- Start
- Jul 2026
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of eculizumab in chronic kidney disease (CKD). Primary endpoint: Primary composite endpoint. Started Jul 2026; status: recruiting.
02
Drugs
eculizumab
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCTs031250214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031250214.